KIMS Q1 FY27 net profit falls 47.2% to Rs 41.5 crore as revenue rises 35.3%
AI Market Summary
KIMS reported a 47% YoY drop in Q1 FY27 net profit despite 35% revenue growth and higher EBITDA, reflecting margin compression as expansion costs rose. Capacity additions and a new hospital launch signal continued growth investment, but near-term profitability pressure may weigh on healthcare sector sentiment. The stock reaction was positive into results, yet earnings quality and margin trajectory are likely to drive short-term positioning.
Impact level
● Low
Affected assets
NCSINIFTY52USD/USDT+1.03%
AI Insight · NCSINIFTY52USD/USDTAI Insight
● Neutral
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Krishna Institute of Medical Sciences (KIMS) reported a 47.2% year-on-year drop in consolidated net profit to Rs 41.5 crore for Q1 FY27, even as revenue from operations rose 35.3% to Rs 1,179.5 crore. EBITDA increased 16% to Rs 223.4 crore, while the EBITDA margin narrowed to 18.9% from 22.1%. The company said it began FY27 on a strong note and launched a new hospital in Palakkad, Kerala.
